| Tender Details | ||||||||
|
||||||||
| Deadline * | ||||||||
|
||||||||
| Client Address | ||||||||
|
||||||||
| More Information | ||||||||
| Know More | ||||||||
Similar Tenders
- Ref No: 9605363
- Location: Russia
Selection Of Organizations With Sufficient Qualifications To Supply Personal Protection Equipment Against Electric Shock Of Induced Voltage Uks With T
- Deadline: 17 Aug 2026
- Ref No: 9605377
- Location: Russia
Selecting Organizations With Sufficient Qualifications To Supply Personal Protection Equipment Against Thermal Risks Of Electric Arc
- Deadline: 28 Aug 2026
- Ref No: 9605391
- Location: Russia
Selecting Organizations With Sufficient Qualifications To Supply Personal Protection Equipment Against Electric Shock And Induced Voltage
- Deadline: 28 Aug 2026
- Ref No: 9868439
- Location: United States
Open Ended School Based Health Center Services Sbhc Rfp
- Deadline: 31 Dec 2099
- Ref No: 5306291
- Location: Germany
Open House Drug Discount Agreements Rivaroxaban Film Coated Tablets Except With A Strength Of 2 5 Mg Atc B01Af01
- Deadline: 05 Apr 2026
- Ref No: 5304038
- Location: Germany
Open House Drug Discount Contracts In Accordance With Section 130A Paragraph 8C Sgb V Pemetrexed Atc L01Ba04
- Deadline: 16 Apr 2026
- Ref No: 5310172
- Location: Germany
Open House Drug Discount Contracts In Accordance With Section 130A Paragraph 8C Sgb V Bortezomib Atc L01Xg01
- Deadline: 16 Apr 2026
- Ref No: 6220889
- Location: Russia
Selecting Organizations With Sufficient Qualifications To Supply Personal Protection Equipment Against Electric Shock And Induced Voltage
- Deadline: 28 Aug 2026
- Ref No: 5396790
- Location: Germany
Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient L
- Deadline: 27 Apr 2026
- Ref No: 5975224
- Location: Germany
Conclusion Of A Non Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingred
- Deadline: 30 Apr 2026
- Ref No: 5227518
- Location: Germany
Medicines With The Active Ingredient Tiotropium Bromide Atc R03Bb04 Except In The Dosage Form Hard Capsules With Powder For Inhalation
- Deadline: 31 Mar 2026
- Ref No: 8267865
- Location: Germany
Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Betamethasone Salicylic Acid
- Deadline: 10 May 2026
- Ref No: 8287659
- Location: Netherlands
Open House Collective Health Insurance For Low Income Earners Municipal Policy Municipality Of Zutphen
- Deadline: 01 Jul 2028
